Related Experiment Video
Updated: Aug 14, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
Aberrant expression of the CD8 antigen in B cell chronic lymphocytic leukaemia
A Espinosa1, P Bjørk, K Magnussen
1Department of Immunology and Transfusion Medicine, University Hospital of Trondheim, St Olavs Hospital, Olav Kyrresg, Trondheim 17, 7006, Norway. aurora.espinosa@rit.no
Insights
This study details a rare case of B cell chronic lymphocytic leukemia (B-CLL) with aberrant CD8 T cell marker expression. The patient responded well to treatment, showing a significant reduction in leukemia cells.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- B cell chronic lymphocytic leukemia (B-CLL) is a common lymphoid malignancy.
- Immunophenotyping is crucial for diagnosing and classifying B-CLL.
- Aberrant antigen expression can occur in B-CLL, impacting prognosis and treatment.
Observation:
- A 62-year-old female presented with enlarged lymph nodes and suspected B-CLL.
- Flow cytometry revealed a typical B-CLL immunophenotype.
- Aberrant expression of the T cell marker CD8 was detected on 64% of leukemic cells.
Findings:
- The co-expression of CD8 on B-CLL cells is a rare finding.
- The clinical significance and biological basis of this CD8 aberrant expression remain to be fully elucidated.
- The patient exhibited a rapid and positive response to treatment.
Implications:
- This case highlights the importance of comprehensive immunophenotyping in B-CLL diagnosis.
- Understanding aberrant antigen expression may lead to novel therapeutic strategies.
- Further research is needed to determine the prognostic and therapeutic implications of CD8 co-expression in B-CLL.
Abstract:
We report a case of aberrant expression of the T cell antigen CD8 in a patient with B cell chronic lymphocytic leukaemia (B-CLL). A 62-year-old Caucasian female with several enlarged lymph nodes and suspected to have B-CLL was referred to our laboratory for routine immunophenotyping. Peripheral blood cell count showed moderate leucocytosis without other abnormalities. The dual-colour flow cytometric analysis showed a typical B-CLL phenotype (CD45+, CD19+, kappa+, lambda-, CD20+, CD23+, IgM+, HLA-DR+, CD5/CD19+, CD3-). In addition, aberrant expression of the T cell marker CD8 was found, present on approximately 64% of the leukemic cells. This is a rare even, the significance and nature of this aberration has not yet been fully determined. In this case, our patient had a rapid response to treatment with a remarkable reduction in the number of leukemic cells only two weeks after beginning treatment.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
07:45Draining Lymph Node Metastasis Model for Assessing the Dynamics of Antigen-Specific CD8+ T Cells During Tumorigenesis
Published on: January 26, 2024
Related Concept Videos
Disorders of Leukocytes
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...